Is it time to consider a role for MRI before prostate biopsy? (original) (raw)

• Cookson, M., Thompson, I. & Thrasher, B. American Urological Association—AUA Update: Guidelines for Prostate Cancer (2006).
• Heidenreich, A. et al. Guidelines on Prostate Cancer. European Association of Urology, Update March (2007).
• Ahmed, H. U. et al. Will focal therapy become a standard of care for men with localized prostate cancer? Nat. Clin. Pract. Oncol. 4, 632–642 (2007).
  Article PubMed Google Scholar
• White, S. et al. Prostate cancer: effect of postbiopsy hemorrhage on interpretation of MR images. Radiology 195, 385–390 (1995).
  Article CAS PubMed Google Scholar
• Saad, F. et al. Canadian surgical wait times (SWAT) initiative. Does prolonging the time to prostate cancer surgery impact long-term cancer control: a systematic review of the literature. Can. J. Urol. 13 (Suppl. 3), 16–24 (2006).
  PubMed Google Scholar
• Vickers, A. J., Bianco, F. J. Jr, Boorjian, S., Scardino, P. T. & Eastham, J. A. Does a delay between diagnosis and radical prostatectomy increase the risk of disease recurrence? Cancer 106, 576–580 (2006).
  Article PubMed Google Scholar
• Department of Health, UK. Tackling hospital waiting: the 18 week patient pathway. An implementation framework. [online 10 May 2006], http://www.pfc.org.uk/files/18_weeks_implimentation.pdf (accessed 5 February 2009).
• Djavan, B. et al. Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop? J. Urol. 166, 1679–1683 (2001).
  Article CAS PubMed Google Scholar
• Jermal, A. et al. Cancer statistics, 2006. CA Cancer J. Clin. 56, 106–130 (2006).
  Article Google Scholar
• McNeal, J. E., Redwine, E. A., Freiha, F. S. & Stamey, T. A. Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread. Am. J. Surg. Pathol. 12, 897–906 (1988).
  Article CAS PubMed Google Scholar
• Kirkham, A. P., Emberton, M. & Allen, C. How good is MRI at detecting and characterising cancer within the prostate? Eur. Urol. 50, 1163–1174 (2006).
  Article PubMed Google Scholar
• Kozlowski, P. et al. Combined diffusion-weighted and dynamic contrast-enhanced MRI for prostate cancer diagnosis—correlation with biopsy and histopathology. J. Magn. Reson. Imaging 2, 108–113 (2006).
  Article Google Scholar
• Hricak, H. MR imaging and MR spectroscopic imaging in the pre-treatment evaluation of prostate cancer. Br. J. Radiol. 78, S103–S111 (2005).
  Article PubMed Google Scholar
• Ikonen, S. et al. Magnetic resonance imaging of clinically localized prostatic cancer. J. Urol. 159, 915–919 (1998).
  Article CAS PubMed Google Scholar
• Zakian, K. L. et al. Correlation of proton MR spectroscopic imaging with gleason score based on step-section pathologic analysis after radical prostatectomy. Radiology 234, 804–814 (2005).
  Article PubMed Google Scholar
• Harlan, S. R. et al. Time trends and characteristics of men choosing watchful waiting for initial treatment of localized prostate cancer: results from CaPSURE. J. Urol. 170, 1804–1807 (2003).
  Article PubMed Google Scholar
• Furuno, T. et al. Difference of cancer core distribution between first and repeat biopsy: in patients diagnosed by extensive transperineal ultrasound guided template prostate biopsy. Prostate 58, 76–81 (2004).
  Article PubMed Google Scholar
• Dhingsa, R. et al. Prostate cancer localization with endorectal MR imaging and MR spectroscopic imaging: effect of clinical data on reader accuracy. Radiology 230, 215–220 (2004).
  Article PubMed Google Scholar
• Muramoto, S. et al. Differentiation of prostate cancer from benign prostate hypertrophy using dual-echo dynamic contrast MR imaging. Eur. J. Radiol. 44, 52–58 (2002).
  Article PubMed Google Scholar
• Futterer, J. J. et al. Standardized threshold approach using three-dimensional proton magnetic resonance spectroscopic imaging in prostate cancer localization of the entire prostate. Invest. Radiol. 42, 116–122 (2007).
  Article PubMed Google Scholar
• Hara, N., Okuizumi, M., Koike, H., Kawaguchi, M. & Bilim, V. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is a useful modality for the precise detection and staging of early prostate cancer. Prostate 62, 140–147 (2005).
  Article PubMed Google Scholar
• Kumar, V. et al. Transrectal ultrasound-guided biopsy of prostate voxels identified as suspicious of malignancy on three-dimensional (1)H MR spectroscopic imaging in patients with abnormal digital rectal examination or raised prostate specific antigen level of 4–10 ng/ml. NMR Biomed. 20, 11–20 (2007).
  Article PubMed Google Scholar
• Villers, A. et al. Dynamic contrast enhanced, pelvic phased array magnetic resonance imaging of localized prostate cancer for predicting tumor volume: correlation with radical prostatectomy findings. J. Urol. 176, 2432–2437 (2006).
  Article PubMed Google Scholar
• Ahmed, H. U. et al. Re: Dynamic contrast enhanced, pelvic phased array magnetic resonance imaging of localized prostate cancer for predicting tumor volume: correlation with radical prostatectomy findings. A. Villers, P. Puech, D. Mouton, X. Leroy, C. Ballereau, L. Lemaitre, J Urol 2006; 176, 2432–2437 J. Urol. 177, 2395 (2007).
  Article Google Scholar
• Sato, C. et al. Differentiation of noncancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheral zones of the prostate. J. Magn. Reson. Imaging 21, 258–262 (2005).
  Article PubMed Google Scholar
• Desouza, N. M., Reinsberg, S. A., Scurr, E. D., Brewster, J. M. & Payne, G. S. Magnetic resonance imaging in prostate cancer: value of apparent diffusion coefficients for identifying malignant nodules. Br. J. Radiol. 80, 90–95 (2007).
  Article CAS PubMed Google Scholar
• Shimofusa, R. et al. Diffusion-weighted imaging of prostate cancer. J. Comput. Assist. Tomogr. 29, 149–153 (2005).
  Article PubMed Google Scholar
• Kumar, V. et al. Correlation between metabolite ratios and ADC values of prostate in men with increased PSA level. Magn. Reson. Imaging 24, 541–548 (2006).
  Article CAS PubMed Google Scholar
• van Dorsten, F. A. et al. Combined quantitative dynamic contrast-enhanced MR imaging and (1)H MR spectroscopic imaging of human prostate cancer. J. Magn. Reson. Imaging 20, 279–287 (2004).
  Article PubMed Google Scholar
• Albertsen, P. C., Hanley, J. A. & Fine, J. 20-year outcomes following conservative management of clinically localized prostate cancer. JAMA 293, 2095–2101 (2005).
  Article CAS PubMed Google Scholar
• Tanimoto, A., Nakashima, J., Kohno, H., Shinmoto, H. & Kuribayashi, S. Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging. J. Magn. Reson. Imaging 25, 146–152 (2007).
  Article PubMed Google Scholar
• Cookson, M. S., Fleshner, N. E., Soloway, S. M. & Fair, W. R. Correlation between Gleason score of needle biopsy and radical prostatectomy specimen: accuracy and clinical implications. J. Urol. 157, 559–562 (1997).
  Article CAS PubMed Google Scholar
• Freedland, S. J. et al. Percent of prostate needle biopsy cores with cancer is significant independent predictor of prostate specific antigen recurrence following radical prostatectomy: results from SEARCH database. J. Urol. 169, 2136–2141 (2003).
  Article PubMed Google Scholar
• Antunes, A. A. et al. The percentage of positive biopsy cores as a predictor of disease recurrence in patients with prostate cancer treated with radical prostatectomy. BJU Int. 96, 1258–1263 (2005).
  Article PubMed Google Scholar
• Kumar, V. et al Potential of 3D 1H MRSI localization of prostate cancer to direct TRUS guided biopsy in patients with PSA 4–10 ng/mL. Proc. Intl Soc. Mag. Reson. Med. 14, 1788 (2006).
  Google Scholar
• Kulkarni, G. S. et al. Evidence for a biopsy derived grade artifact among larger prostate glands. J. Urol. 175, 505–509 (2006).
  Article PubMed Google Scholar
• Ikonen, S. et al. Magnetic resonance imaging of prostatic cancer: does detection vary between high and low gleason score tumors? Prostate 43, 43–48 (2000).
  Article CAS PubMed Google Scholar
• Mazahari, Y., Koutcher, J. A., Shukla-Dave, A. & Hricak, H. Imaging and multi-parametric analysis of cancerous tissue (IMPACT): Prostate Cancer (PCa). Proc. Intl Soc. Mag. Reson. Med. 14, 3497 (2003).
  Google Scholar
• Rouvière, O. et al. Characterization of time-enhancement curves of benign and malignant prostate tissue at dynamic MR imaging. Eur. Radiol. 13, 931–942 (2003).
  Article PubMed Google Scholar
• Girouin, N. et al. Prostate dynamic contrast-enhanced MRI with simple visual diagnostic criteria: is it reasonable? Eur. Radiol. 17, 1498–1509 (2007).
  Article PubMed Google Scholar
• Cantor, S. B., Volk, R. J., Cass, A. R., Gilani, J. & Spann, S. J. Psychological benefits of prostate cancer screening: the role of reassurance. Health Expect. 5, 104–113 (2002).
  Article PubMed PubMed Central Google Scholar
• Wefer, A. E. et al. Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology. J. Urol. 164, 400–404 (2000).
  Article CAS PubMed Google Scholar
• Beyersdorff, D. et al. Patients with a history of elevated prostate-specific antigen levels and negative transrectal US-guided quadrant or sextant biopsy results: value of MR imaging. Radiology 224, 701–706 (2002).
  Article PubMed Google Scholar
• Prando, A., Kurhanewicz, J., Borges, A. P., Oliveira, E. M. Jr. & Figueiredo, E. Prostatic biopsy directed with endorectal MR spectroscopic imaging findings in patients with elevated prostate specific antigen levels and prior negative biopsy findings: early experience. Radiology 236, 903–910 (2005).
  Article PubMed Google Scholar
• Comet-Batlle, J., Vilanova-Busquets, J. C., Saladie-Roig, J. M., Gelabert-Mas, A. & Barcelo-Vidal, C. The value of endorectal MRI in the early diagnosis of prostate cancer. Eur. Urol. 44, 201–207 (2003).
  Article CAS PubMed Google Scholar
• Nijs, H. G., Essink-Bot, M. L., DeKoning, H. J., Kirkels, W. J. & Schroder, F. H. Why do men refuse or attend population-based screening for prostate cancer? J. Public Health Med. 22, 312–316 (2000).
  Article CAS PubMed Google Scholar
• Mkinen, T., Auvinen A, Hakama, M., Stenman, U. H. & Tammela, T. L. Acceptability and complications of prostate biopsy in population-based PSA screening versus routine clinical practice: a prospective, controlled study. Urology 60, 846–850 (2002).
  Article PubMed Google Scholar
• Bossuyt, P. M., Irwig, L., Craig, J. & Glasziou, P. Comparative accuracy: assessing new tests against existing diagnostic pathways. BMJ 332, 1089–1092 (2006).
  Article PubMed PubMed Central Google Scholar
• Morgan, D., Ahmed, H. U., Emberton, M., Hawkes, D. & Barratt, D. Registration of preoperative MR to intraoperative ultrasound images for guiding minimally invasive prostate interventions [Abstract]. Proc. Medical Image Understanding and Analysis (MIUA) 181–185 (2007).
• Singh, A. K. Initial clinical experience with real-time transrectal ultrasonography-magnetic resonance imaging fusion-guided prostate biopsy. BJU Int. 101, 841–845 (2008).
  Article PubMed Google Scholar
• Hricak, H., Choyke, P. L., Eberhardt, S. C., Leibel, S. A. & Scardino, P. T. Imaging prostate cancer: a multidisciplinary perspective. Radiology 245, 28–53 (2007).
  Article Google Scholar
• Fütterer, J. J. MR imaging in local staging of prostate cancer. Eur. J. Radiol. 63, 328–334 (2007).
  Article PubMed Google Scholar
• Rifkin, M. D. et al. Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer. Results of a multi-institutional cooperative trial. N. Engl. J. Med. 323, 621–626 (1990).
  Article CAS PubMed Google Scholar
• Sonnad, S. S., Langlotz, C. P. & Schwartz, J. S. Accuracy of MR imaging for staging prostate cancer: a meta-analysis to examine the effect of technologic change. Acad. Radiol. 8, 149–157 (2001).
  Article CAS PubMed Google Scholar
• Engelbrecht, M. R. et al. Local staging of prostate cancer using magnetic resonance imaging: a meta-analysis. Eur. Radiol. 12, 2294–2302 (2002).
  Article PubMed Google Scholar
• Huch Boni, R. A. et al. Optimization of prostate carcinoma staging: comparison of imaging and clinical methods. Clin. Radiol. 50, 593–600 (1995).
  Article CAS PubMed Google Scholar
• Hering, F., Rist, M., Roth, J., Mihatsch, M. & Ruishauser, G. Does microinvasion of the capsule and/or micrometastases in regional lymph nodes influence disease-free survival after radical prostatectomy? Br. J. Urol. 66, 177–181 (1990).
  Article CAS PubMed Google Scholar
• Epstein, J. I., Partin, A. W., Sauvageot, J. & Walsh, P. C. Prediction of progression following radical prostatectomy. A multivariate analysis of 721 men with long-term follow-up. Am. J. Surg. Path. 20, 286–292 (1996).
  Article CAS PubMed Google Scholar
• Jager, G. J. et al. Local staging of prostate cancer with endorectal MR imaging: correlation with histopathology. AJR Am. J. Roentgenol. 166, 845–852 (1996).
  Article CAS PubMed Google Scholar
• Wang, L. et al. Prediction of organ-confined prostate cancer: incremental value of MR imaging and MR spectroscopic imaging to staging nomograms. Radiology 238, 597–603 (2006).
  Article PubMed Google Scholar
• Wetter, A. et al. Combined MRI and MR spectroscopy of the prostate before radical prostatectomy. AJR Am. J. Roentgenol. 187, 724–730 (2006).
  Article PubMed Google Scholar
• Jager, G. J. et al. Dynamic TurboFLASH subtraction technique for contrast-enhanced MR imaging of the prostate: correlation with histopathology. Radiology 203, 645–652 (1997).
  Article CAS PubMed Google Scholar
• Futterer, J. J. et al. Staging prostate cancer with dynamic contrast-enhanced endorectal MR imaging prior to radical prostatectomy: experienced versus less experienced readers. Radiology 237, 541–549 (2005).
  Article PubMed Google Scholar
• Huch Boni, R. A. et al. Contrast-enhanced endorectal coil MRI in local staging of prostate carcinoma. J. Comput. Assist. Tomogr. 19, 232–237 (1995).
  Article CAS PubMed Google Scholar
• Lange, P. H. & Narayan, P. Understaging and undergrading of prostate cancer. Argument for postoperative radiation as adjuvant therapy. Urology 21, 113–118 (1983).
  Article CAS PubMed Google Scholar
• D'Amico, A. V. et al. Critical analysis of the ability of the endorectal coil magnetic resonance imaging scan to predict pathologic stage, margin status, and postoperative prostate-specific antigen failure in patients with clinically organ-confined prostate cancer. J. Clin. Oncol. 14, 1770–1777 (1996).
  Article CAS PubMed Google Scholar
• Cheng, G. C. et al. Clinical utility of endorectal MRI in determining PSA outcome for patients with biopsy Gleason score 7, PSA < or = 10, and clinically localized prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 55, 64–70 (2003).
  Article PubMed Google Scholar
• D'Amico, A. V. et al. Endorectal magnetic resonance imaging as a predictor of biochemical outcome after radical prostatectomy in men with clinically localized prostate cancer. J. Urol. 164, 759–763 (2000).
  Article CAS PubMed Google Scholar
• Clarke, D. H. et al. The role of endorectal coil MRI in patient selection and treatment planning for prostate seed implants. Int. J. Radiat. Oncol. Biol. Phys. 52, 903–910 (2002).
  Article PubMed Google Scholar
• Hricak, H. et al. The role of preoperative endorectal magnetic resonance imaging in the decision regarding whether to preserve or resect neurovascular bundles during radical retropubic prostatectomy. Cancer 100, 2655–2663 (2004).
  Article PubMed Google Scholar
• Coakley, F. V. et al. Urinary continence after radical retropubic prostatectomy: relationship with membranous urethral length on preoperative endorectal magnetic resonance imaging. J. Urol. 168, 1032–1035 (2002).
  Article PubMed Google Scholar
• Lee, S. E. et al. Impact of variations in prostatic apex shape on early recovery of urinary continence after radical retropubic prostatectomy. Urology 68, 137–141 (2006).
  Article PubMed Google Scholar
• Coakley, F. V. et al. Blood loss during radical retropubic prostatectomy: relationship to morphologic features on preperative endorectal magnetic resonance imaging. Urology 59, 884–888 (2002).
  Article PubMed Google Scholar
• Zietman, A. L. et al. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. JAMA 294, 1233–1239 (2005).
  Article CAS PubMed Google Scholar
• Roach, M. 3rd, Faillace-Akazawa, P., Malfatti, C., Holland, J. & Hricak, H. Prostate volumes defined by magnetic resonance imaging and computerized tomographic scans for three-dimensional conformal radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 35, 1011–1018 (1996).
  Article PubMed Google Scholar
• Rasch, C. et al. Definition of the prostate in CT and MRI: a multi-observer study. Int. J. Radiat. Oncol. Biol. Phys. 43, 57–66 (1999).
  Article CAS PubMed Google Scholar
• Steenbakkers, R. J. et al. Reduction of dose delivered to the rectum and bulb of the penis using MRI delineation for radiotherapy of the prostate. Int. J. Radiat. Oncol. Biol. Phys. 57, 1269–1279 (2003).
  Article PubMed Google Scholar
• Villeirs, G. M. & De Meerleer, G. O. Magnetic resonance imaging (MRI) anatomy of the prostate and application of MRI in radiotherapy planning. Eur. J. Radiol. 63, 361–368 (2007).
  Article PubMed Google Scholar
• Roach, M. 3rd. Is it time to change the standard of care from CT to MRI for defining the apex of the prostate to accomplish potency-sparing radiotherapy? Int. J. Radiat. Oncol. Biol. Phys. 61, 1–2 (2005).
  Article PubMed Google Scholar
• McLaughlin, P. W. et al. Vessel-sparing prostate radiotherapy: dose limitation to critical erectile vascular structures (internal pudendal artery and corpus cavernosum) defined by MRI. Int. J. Radiat. Oncol. Biol. Phys. 61, 20–31 (2005).
  Article PubMed Google Scholar
• Buyyounouski, M. K. et al. Intensity-modulated radiotherapy with MRI simulation to reduce doses received by erectile tissue during prostate cancer treatment. Int. J. Radiat. Oncol. Biol. Phys. 58, 743–749 (2004).
  Article PubMed Google Scholar
• Mizowaki, T. et al. Towards integrating functional imaging in the treatment of prostate cancer with radiation: the registration of the MR spectroscopy imaging to ultrasound/CT images and its implementation in treatment planning. Int. J. Radiat. Oncol. Biol. Phys. 54, 1558–1564 (2002).
  Article PubMed Google Scholar
• Huisman, H. J. et al. Prostate cancer: precision of integrating functional MR imaging with radiation therapy treatment by using fiducial gold markers. Radiology 236, 311–317 (2005).
  Article PubMed Google Scholar
• Atalar, E. & Menard, C. MR-guided interventions for prostate cancer. Magn. Reson. Imaging Clin. N. Am. 13, 491–504 (2005).
  Article PubMed Google Scholar
• Crawford, E. D. et al. Clinical staging of prostate cancer: a computer-simulated study of transperineal prostate biopsy. BJU Int. 96, 999–1004 (2005).
  Article PubMed Google Scholar
• Satoh, T. et al. Cancer core distribution in patients diagnosed by extended transperineal prostate biopsy. Urology 66, 114–118 (2005).
  Article PubMed Google Scholar
• Gosselaar, C, Roobol, M. J. & Schroder, F. H. Prevalence and characteristics of screen-detected prostate carcinomas at low prostate-specific antigen levels: aggressive or insignificant? BJU Int. 95, 231–237 (2005).
  Article PubMed Google Scholar
• Lagerburg, V., Moerland, M. A., Lagendijk, J. J. & Battermann, J. J. Measurement of prostate rotation during insertion of needles for brachytherapy. Radiother. Oncol. 77, 318–323 (2005).
  Article PubMed Google Scholar
• Sakr, W. A. et al. High grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinoma between the ages of 20–69: an autopsy study of 249 cases. In Vivo 8, 439–443 (1994).
  CAS PubMed Google Scholar
• Zhan, Y., Feldman, M., Tomaszeweski, J., Davatzikos, C. & Shen, D. Registering histological and MR images of prostate for image-based cancer detection. Med. Image Comput. Comput. Assist. Interv. Int. Conf. Med. Image Comput. Comput. Assist. Interv. 9, 620–628 (2006).
  Google Scholar
• Miller, J., Perumalla, C. & Heap, G. Complications of transrectal versus transperineal prostate biopsy. ANZ J. Surg. 75, 48–50 (2005).
  Article PubMed Google Scholar
• Carter, H. B. et al. Nonpalpable prostate cancer: detection with MR imaging. Radiology 178, 523–525 (1991).
  Article CAS PubMed Google Scholar
• Wise, A. M., Stamey, T. A., McNeal, J. E. & Clayton, J. L. Morphologic and clinical significance of multifocal prostate cancers in radical prostatectomy specimens. Urology 60, 264–269 (2002).
  Article PubMed Google Scholar
• Klotz, L. Active surveillance for prostate cancer: for whom? J. Clin. Oncol. 23, 8165–8169 (2005).
  Article PubMed Google Scholar
• Hardie, C. et al. Early outcomes of active surveillance for localized prostate cancer. BJU Int. 95, 956–960 (2005).
  Article PubMed Google Scholar
• Kikuchi, E., Scardino, P. T., Wheeler, T. M., Slawin, K. M. & Ohori, M. Is tumor volume an independent prognostic factor in clinically localized prostate cancer? J. Urol. 172, 508–511 (2004).
  Article PubMed Google Scholar
• Sengupta, S. et al. After radical retropubic prostatectomy 'insignificant' prostate cancer has a risk of progression similar to low-risk 'significant' cancer. BJU Int. 101, 170–174 (2008).
  Article PubMed Google Scholar
• Shukla-Dave, A. et al. The utility of magnetic resonance imaging and spectroscopy for predicting insignificant prostate cancer: an initial analysis. BJU Int. 99, 786–793 (2007).
  Article CAS PubMed Google Scholar
• Health and Social Care Information Centre. Hospital Episode Statistics 2004–2005 Department of Health, United Kingdom, December (2005). http://www.hesonline.nhs.uk (accessed 1 August 2008).
• Abella, H. A. Lack of national diagnosis, care plan spurs call for action. Diagnostic Imaging 36–38 (2008) http://www.diagnosticimaging.com (accessed 1 January 2008).
• Miller, D. C., Gruber, S. B., Hollenbeck, B. K., Montie, J. E. & Wei, J. T. Incidence of initial local therapy among men with lower-risk prostate cancer in the United States. J. Natl Cancer Inst. 98, 1134–1141 (2006).
  Article PubMed Google Scholar
• Cooperberg, M. R., Moul, J. W. & Carroll, P. The changing face of prostate cancer. J. Clin. Onc. 23, 8146–8151 (2005).
  Article Google Scholar
• Bill-Axelson, A. et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N. Engl. J. Med. 352, 1977–1984 (2005).
  Article CAS PubMed Google Scholar